The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations

Pharmacogenetics

Volumn 9, Issue 1, 1999, Pages 37-42

  Collie Duguid, E S R ^a   Pritchard, S C ^a   Powrie, R H ^a   Sludden, J ^a   Collier, D A ^b   Li, T ^b,c   McLeod, H L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Ethnic variation; Genetic polymorphism; Pharmacogenetics; Thiopurine methyltransferase

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; DRUG RESPONSE; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0032917646     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199902000-00006     Document Type: Article

References (22)

1. Citera G, Wilson WA. Ethnic and geographic perspectives in SLE. Lupus 1993;2:351-353.
2. Cohen RD, Hanauer SB. Immunomodulatory agents and other medical therapies in inflammatory bowel disease. Curr Opin Gastroenter 1995; 11:321-330.
3. Escousse A, Rifle G, Sgro C, Mousson C, Zanetta G, Chevel D. Azathioprine toxicity, 6-mercaptopurine accumulation and the 'poor' 6-thiopurine methylator phenotype. Eur J Clin Pharmacol 1995; 48:309-310.
4. Gaston RS, Ayres I, Dooley LG, Diethelm AG. Racial equity in renal transplantation: the disparate impact of HLA based allocation. JAMA 1993; 11:1352-1356.
5. Kerstens PJSM, Stolk JN, Deabreu RA, Lambooy LHJ, Van Deputte LBA, Boerbooms AAMT. Azathioprine-relaled bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid-arthritis. Arthritis Rheumat 1995; 38:142-145.
6. Klemetsdal B,Tollefsen E, Loennechen T, Johnsen K, Utsi E, Gisholt K, et al. Interethnic difference in thiopurine methyltransferase activity. Clin Pharmacol Ther 1992; 51:24-31.
7. Krynetski EY, Schuetz JD, Galpin AJ, Pui C-H, Relling M, Evans WE. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci U S A 1995; 92:949-953.
8. Krynetski EY, Tai H-L, Yates CR, Fessing MY, Loennechen T, Schuetz JD. et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics 1996; 6:279-290.
9. Krynetski EY, Fessing MY, Yates CR, Sun D, Schuetz JD, Evans WE. Promoter and intronic sequences of the human thiopurine S-methyltransferase (TPMT) gene isolated from a human Pac 1 genomic library. Pharm Res 1997; 14:1672-1678.
10. Leipold G, Schutz E, Haas JP, Oellerich M. Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. Arthrit Rheumat 1997; 40:1896-1898.
11. Li T, Vallada H, Curtis D, Arranz M, Xu K, Cai G, et al. Catechol-O-methyltransferase Val58Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 1997; 7:349-353.
12. McLeod HL, Miller DR, Evans WE. Azathioprine-induced myclosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341:1151.
13. McLeod HL, Lin J-S, Scott EP, Pui C-H, Evans WE. Thiopurine methyltransferase activity in American while subjects and black subjects. Clin Pharmacol Ther 1994; 55:15-20.
14. McLeod HL, Relling MV, Liu Q, Pui C-H, Evans WE, Polymorphic thiopurine methyltransferase in crythrocytes is indicative of activity in leukaemic blasts from children with acute lymphoblastic leukaemia. Blood 1995; 85:1897-1902.
15. McLeod HL, Syvänen A-C, Githang'a J, Indalo A, Ismail D, Dewar K, et al. Ethnic differences in Catechol-O-methyltransferase pharmacogenetics: frequency of codon 108/1 58 low activity allele is lower in Kenyan than Caucasian or Southwest Asian subjects. Pharmacogenetics 1998; 8, 195-199.
16. Nei M, Saitou N. In: Kalow W, Goedde HW, Agarwal DP, editors. Ethnic differences in reaction to drugs and xenobiotics. New York, NY: Alan R Liss; 1986. pp. 21-37.
17. Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Han JO, et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphism. Clin Pharmacol Ther 1997; 62:60-73.
18. Schutz E, Gummert J, Mohr F, Oellerich M. Azathioprine-indueed myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 1993; 341:436.
19. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996; 15:17-30.
20. Tai H-L, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, Evans WE. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996; 58:694-702.
21. Tai H-L, Krynetski EY, Schuctz, EG, Yanishevski Y, Evans WE. Enhanced protcolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): Mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci U S A 1997; 94:6444-6449.
22. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai H-L, Pui C-H, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126:608-614.